Status:
UNKNOWN
Effects of Transcranial Magnetic Stimulation Associated to Sensory Therapy for Treatment of Motor Function of Upper Limb of Stroke Patients
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Stroke
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
The aim of this research will be to investigate in stroke patients whether upper limb motor function can be maximized in response to sensory stimulation by comparing protocols for the application of T...
Eligibility Criteria
Inclusion
- diagnosis of ischemic or hemorrhagic stroke proven by means of computed tomography or magnetic resonance imaging,
- absence of cognitive deficits (evaluated by Mini Mental State Examination, score ≥ 20 - FOLSTEIN 1975);
- partially preserved motor functions (evaluated by the Fugl-Meyer Scale, score between 14 and 60, due to the necessary movements to be performed during the intervention);
- partially preserved sensorial (evaluated by the Fugl-Meyer Scale, score between 2 and 10 in the sensorial item , Indicating subjects with sensorial alterations but without extinction of the sensation) (MAKI, QUAGLIATO, CACHO, et al., 2006);
- patients who, through exposure to electric current by TENS, perceive the electrical stimulation in the palm, back of the hand and ventral forearm will be included.
Exclusion
- clinical evidence of multiple brain lesions or other associated neurological diseases;
- peripheral neuropathies;
- leprosy;
- fibromyalgia;
- rheumatoid arthritis;
- other upper and lower motor neuron pathologies;
- sensitizing skin diseases;
- history of psychiatric illnesses including drug and alcohol abuse;
- traumato-orthopedic deformities installed in upper limbs;
- those who are performing some rehabilitation treatment during the collection (Physiotherapy and / or Occupational Therapy) will not participate in the research.
- In addition, for the application of rTMS:
- patients with intracranial metal implants will be excluded;
- pregnancy;
- history of seizures and / or epilepsy;
- use of medication that interferes with cortical excitability.
Key Trial Info
Start Date :
July 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03329807
Start Date
July 20 2017
End Date
August 30 2019
Last Update
November 6 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Pernambucano
Recife, Pernambuco, Brazil, 50740-560
2
Aristela de Freitas Zanona
Recife, Brazil